Diagnosis:
Consortium-wide triage approach to diagnose your business needs and implement a bespoke
development plan.

Diversification: 
Leveraging the strengths of regional manufacturing innovation to upskill companies and support non-sector companies/supply chains to pivot into Health Tech industry.

Deployment: 
Real-world NHS product usability testing & evaluation services and international market access
support.

Development: 
Access to expert infrastructure and innovation support for product development including
prototyping, regulation, clinical trials and evaluation.

Definition: 
Programmes of targeted training & support to ensure your innovation effects focus on addressing
the most critical needs in the healthcare sector.

Demonstration: 
Ongoing evaluation and sustainability work to refine activities and create regional/national evidence
bases for 'what works' in Health Tech sectoral support - building long-term investment platforms.

We have forged a collaborative partnership of expertise that can help you navigate the challenges of bringing new healthcare devices, diagnostics and digital innovations to the market.

Our approach provides comprehensive support at every stage of innovation development, by bringing together a range of regional partners with complementary expertise. From initial business planning and bespoke programmes of training, through to assisted prototyping and real-world NHS testing services.

The WMHTIA’s wide-reaching network can also provide access to nationwide infrastructure and links to the international trade market.

The only requirement to partake in our programme is to be a West Midlands based innovator or for your innovation to directly contribute to the growth of the region – either by setting up your business or supply chains here.

Whether your company is a start-up, SME or an established firm - as long as your operations will benefit the West Midlands - we encourage you to seize this opportunity and participate in this exciting development of the region’s Health Tech landscape.

No. Whilst our support focuses on driving rapid innovation development and business impact from TRLs 3-7, our programme is open to innovators of all readiness levels.

To submit your expression of interest, click the “Register interest” button on the top of our homepage and complete the provided form.

Need more information? Get in touch with us via wmhtia@contacts.bham.ac.uk

The WMHTIA has been designed with a long-term vision in mind, bringing together a range of partners who have longstanding commitments to this area of innovation.

Beyond our initial 2-year timeline, we will continue fostering the region’s Health Tech sector.

So, from day one, our focus is set on attracting further investment to ensure sustainability in the West Midlands that nurtures growth for innovators long after the initial programme period.

Our approach is not limited to offering minimal, one-time support. We strive to engage in long-term development that will help you make significant progress towards commercialisation, implementation, and market uptake.

As a result, support programmes will vary on a case-by-case basis – subject to the identified needs and opportunities during your programme entry point.

Our consortium’s combined expertise will offer a wide array of support which will be subject to competitive resource allocation and tangible delivery of results.

If your service or innovation solves a healthcare challenge – we want to hear about it!

A vital aspect to our programme’s success is leveraging the pre-existing strengths of the West Midlands. A model example is the region’s rich manufacturing history – which has established supply chains that offer the perfect opportunity for non-sector companies to pivot into the Health Tech industry.

Not sure whether you comply? Get in touch with us via wmhtia@contacts.bham.ac.uk

Alongside our programme of support, we will also be running a secondary grant scheme competition for SMEs.

More details will follow but to reassure you – it’s not as uncompromising as a conventional 50% financial contribution.